Cjc-1295 Dac Vente En Ligne

Direct Answer: Sourcing CJC-1295 DAC Online for Laboratory Research

Sourcing CJC-1295 DAC online (vente en ligne) for scientific research requires verifying that the compound is supplied as a reference-grade lyophilized peptide with batch-specific analytical authentication. CJC-1295 with Drug Affinity Complex (DAC) is a modified growth-hormone-releasing hormone (GHRH) analog designed to bioconjugate with endogenous albumin in preclinical models, significantly extending its biological half-life.

To ensure experimental reproducibility, researchers must source CJC-1295 DAC from validated domestic facilities that provide lot-specific certificates of analysis (COA), high-performance liquid chromatography (HPLC) chromatograms, mass spectrometry (MS) characterization, and strict endotoxin testing.

Chemical Structure and the Drug Affinity Complex (DAC) Mechanism

CJC-1295 DAC is a synthetic 29-amino acid tetrasubstituted peptide derivative of natural GHRH (1-29), featuring a reactive maleimidopropionic acid (MPA) linker attached via a lysine residue at the C-terminus. This structural modification constitutes the Drug Affinity Complex (DAC) technology, which allows the molecule to covalently bind to circulating serum albumin upon administration in animal models.

In physiological and preclinical research, un-complexed peptides typically undergo rapid enzymatic degradation by dipeptidyl peptidase IV (DPP-IV) and neutral endopeptidases, resulting in biological half-lives of mere minutes. The addition of the DAC moiety protects the peptide cleavage sites without altering its affinity for the GHRH receptor. Preclinical studies indicate that this modification extends the biological half-life from approximately 30 minutes to over 6 to 8 days in rodent and non-human primate models.

Researchers evaluating GHRH receptor stimulation pathways utilize CJC-1295 DAC to examine sustained, non-pulsatile activation of pit-1 nuclear transcription factor, downstream somatotroph transcription, and continuous growth hormone gene expression without requiring frequent dosing intervals in experimental protocols.

Preclinical Literature: Endocrine Modulation and Tissue Repair Research

The primary focus of academic research surrounding CJC-1295 DAC centers on its capacity to sustain elevated concentrations of systemic growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Unlike native GHRH, which induces transient, high-amplitude GH spikes, CJC-1295 DAC maintains elevated basal GH concentrations across extended experimental timeframes.

In animal models, sustained IGF-1 elevation driven by GHRH receptor agonism plays a critical role in cellular proliferation, protein translation, and tissue regeneration. Preclinical data show that prolonged GHRH axis activation promotes satellite cell activation in skeletal muscle tissue, enhances collagen synthesis in connective tissues, and accelerates cellular recovery in wound healing assays.

Furthermore, preclinical investigations published in our research library hub examine the role of long-acting GHRH analogs in lipid metabolism and nitrogen balance. In vivo rodent models demonstrate marked increases in lipolysis and nitrogen retention during sustained CJC-1295 DAC exposure, providing valuable insights into metabolic homeostasis, sarcopenia, and cellular repair mechanisms.

Comparative Analysis: CJC-1295 DAC vs. Non-DAC and Secretagogues

When designing peptide protocols for growth hormone signaling research, investigators often compare GHRH analogs with selective growth hormone secretagogues (GHS) and ghrelin receptor agonists. Selecting the appropriate research compound depends heavily on whether the experimental model requires continuous basal stimulation or pulsatile GH release.

Comparative studies highlight key operational differences across this peptide class. While CJC-1295 DAC provides continuous GHRH receptor activation via its albumin-binding MPA linker, CJC-1295 No DAC (also known as Modified GRF 1-29) lacks the bioconjugation complex, producing rapid, transient GH pulses ideal for mimicking physiological secretion patterns. Conversely, ghrelin receptor agonists such as Ipamorelin and GHRP-6 act on the growth hormone secretagogue receptor (GHS-R1a), operating through synergistic signaling pathways when co-administered with GHRH analogs in cell line models.

Researchers exploring the broader spectrum of somatotroph-stimulating peptides can browse our full catalog of all peptides to compare molecular weights, purity specifications, and receptor binding affinities across different secretagogue classes.

Evaluating Online Supplier Quality: Strict Analytical Requirements

When purchasing research compounds online (vente en ligne), laboratory managers must look beyond basic vendor claims and evaluate verifiable quality control parameters. Because synthetic peptide impurities—such as truncated sequences, deletion peptides, and leftover TFA salts—can alter experimental outcomes or induce cellular toxicity in vitro, rigorous quality assurance is non-negotiable.

PX1 Research enforces strict manufacturing and analytical criteria for every lot of CJC-1295 DAC:

• High-Performance Liquid Chromatography (HPLC): Guarantees chemical purity levels of ≥99.0%, ensuring that residual synthesis byproducts do not interfere with cell assay kinetics.

• Mass Spectrometry (MS): Confirms exact molecular weight and identity matching the theoretical monoisotopic mass of the peptide-DAC construct.

• Endotoxin Testing: Verifies bacterial endotoxin levels are maintained below strictly defined laboratory limits (<0.01 EU/mg) using chromogenic LAL assays, safeguarding cell culture viability.

• ISO 17025 Third-Party Testing: Every batch undergoes independent analytical verification at accredited testing laboratories, with lot-matched COAs published directly for institutional verification.

• USA Manufacturing: Produced in GMP-compliant, USA-based facilities adhering to rigid synthesis and purification standards, eliminating cross-contamination risks associated with unverified overseas distributors.

Laboratory Handling, Reconstitution, and Storage Protocols

To maintain peptide integrity and prevent chemical degradation, laboratory personnel must follow standardized handling procedures upon receipt of lyophilized CJC-1295 DAC vials.

1. Storage upon arrival: Store the unopened, lyophilized peptide vial in a desiccated freezer at -20°C to -80°C. Under sub-zero conditions, the dry peptide remains stable for extended research timelines.

2. Reconstitution: Allow the vial to equilibrate to room temperature before opening to prevent condensation inside the container. Reconstitute using sterile bacteriostatic water or an appropriate laboratory buffer. Direct the solvent slowly down the glass wall of the vial rather than shooting it directly onto the lyophilized cake.

3. Solubilization: Gently swirl the vial until the powder is fully dissolved. Never shake or agitate the solution vigorously, as mechanical shear stress can denature the tertiary structure of fragile peptide chains. For complete laboratory protocols, refer to our detailed peptide reconstitution guide.

4. Aliquoting and Storage: Following reconstitution, aliquot the working solution into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles. Store reconstituted aliquots at 2°C to 8°C for short-term assays or freeze at -80°C for long-term storage.

In Vitro Assays and Preclinical Experimental Applications

In laboratory settings, CJC-1295 DAC serves as a vital tool for elucidating GHRH receptor kinetics, intracellular cyclic AMP (cAMP) generation, and downstream gene transcription. In vitro experiments using primary pituitary cell cultures or transfected somatotroph cell lines utilize the peptide to study signal transduction pathways under sustained agonist exposure.

Researchers investigating GHRH analogs also examine the interplay between continuous GHRH exposure and receptor desensitization or downregulation. Unlike short-acting GHRH derivatives, CJC-1295 DAC allows investigators to map receptor internalization dynamics, beta-arrestin recruitment, and long-term IGF-1 gene promoter activity in hepatic cell cultures.

For additional scientific background on GHRH receptor binding and signaling cascades, explore our dedicated review on GHRH analogs mechanism.

Institutional Procurement and Regulatory Compliance

PX1 Research operates strictly as a supplier of reference-grade research chemicals intended for laboratory, educational, and preclinical research environments. CJC-1295 DAC is explicitly NOT sold for human consumption, therapeutic use, clinical administration, or veterinary treatment.

Academic institutions, biotechnology organizations, and contract research facilities (CROs) can establish dedicated supply lines through our wholesale lab accounts program. This service provides volume pricing, dedicated batch reservation, and comprehensive documentation packages required for institutional compliance and internal safety audits.